Nature Communications, 2020 · DOI: https://doi.org/10.1038/s41467-020-18265-3 · Published: September 9, 2020
This research introduces a new approach to treating acute spinal cord injuries by creating a scaffold that responds to the injury's acidic environment. This scaffold releases medication to reduce inflammation and encourage nerve regeneration. The scaffold is made of electrospun fibers loaded with an IL-4 plasmid and nerve growth factor (NGF). The IL-4 plasmid aims to suppress inflammation, while NGF promotes neural differentiation of mesenchymal stem cells. By regulating the immune response and promoting nerve regeneration simultaneously, this strategy offers a potential solution to the challenges of treating acute spinal cord injuries.
The microenvironment-responsive immunoregulatory electrospun fibers can be utilized as a therapeutic strategy for acute spinal cord injury.
The designed scaffold can be used as a delivery system for sustained and triggered release of therapeutic agents.
The immunomodulatory effect of the scaffold can be applied in other inflammation-related diseases.